However, animal studies have indicated that elevated FGF-21 levels or treatment with FGF-21 leads to improved glucose and lipid metabolism, weight loss, and NAFLD (34, 35). This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.